|
Sign In to gain access to subscriptions and/or personal tools.
|
Distinct roles for IP-10/C XC L10 in three animal models, Theiler’s virus infection, EA E, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10
Ikuo Tsunoda
Department of Neurology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132-2305, USA
Thomas E Lane
Department of Molecular Biology and Biochemistry, University of California, 3205 Biological Sciences II, Irvine, CA 92697-3900, USA
Jana Blackett
Department of Neurology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132-2305, USA
Robert S Fujinami
Department of Neurology, University of Utah School of Medicine, 30 North 1900 East, Salt Lake City, UT 84132-2305, USA, Robert.Fujinami{at}hsc.utah.edu
Theiler’s murine encephalomyelitis virus (TMEV) causes demyelination with inflammation of the central nervous system (C NS) in mice and is used as an animal model for multiple sclerosis (MS). Interferon-g inducible protein-10 kDa (IP-10) is a C XC chemokine and a chemoattractant for C XC R3+ T cells. IP-10 mRNA is expressed in the C NS during TMEV infection. However, administration of anti-IP- 10 serum caused no difference in clinical signs, inflammation, demyelination, virus persistence or anti-virus antibody response in TMEV infection, while levels of virus specific and autoreactive lymphoproliferation increased. This likely reflects a difference in the pathogenesis of TMEV infection from that of two other animal models for MS, mouse hepatitis virus infection and experimental allergic encephalomyelitis (EAE), where blocking of IP-10 resulted in clinical and histological improvement with suppression of antigen specific lymphoproliferation. In this review, we compare and contrast the roles of IP-10 between the three animal models for MS, and discuss the relevance to MS patients with different clinical courses.
Key Words: allergy and immunology • autoimmunity • Cardiovirus infections • histology • immunotherapy • Picornaviridae infections
Multiple Sclerosis, Vol. 10, No. 1,
26-34 (2004)
DOI: 10.1191/1352458504ms982oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
J. L. Konopka, J. M. Thompson, A. C. Whitmore, D. L. Webb, and R. E. Johnston
Acute Infection with Venezuelan Equine Encephalitis Virus Replicon Particles Catalyzes a Systemic Antiviral State and Protects from Lethal Virus Challenge
J. Virol.,
December 1, 2009;
83(23):
12432 - 12442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. A. Lin, P. K. Tripathi, A. Sholl, M. B. Jordan, and D. A. Hildeman
Gamma Interferon Signaling in Macrophage Lineage Cells Regulates Central Nervous System Inflammation and Chemokine Production
J. Virol.,
September 1, 2009;
83(17):
8604 - 8615.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yuan, Z. Liu, T. Lim, H. Zhang, J. He, E. Walker, C. Shier, Y. Wang, Y. Su, A. Sall, et al.
CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis
Circ. Res.,
March 13, 2009;
104(5):
628 - 638.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Riemer, J. Schultz, M. Burwinkel, A. Schwarz, S. W. F. Mok, S. Gultner, T. Bamme, S. Norley, F. van Landeghem, B. Lu, et al.
Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3-/- Mice
J. Virol.,
December 15, 2008;
82(24):
12464 - 12471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tsunoda, T. Tanaka, Y. Saijoh, and R. S. Fujinami
Targeting Inflammatory Demyelinating Lesions to Sites of Wallerian Degeneration
Am. J. Pathol.,
November 1, 2007;
171(5):
1563 - 1575.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Kercher, C. Favara, J. F. Striebel, R. LaCasse, and B. Chesebro
Prion Protein Expression Differences in Microglia and Astroglia Influence Scrapie-Induced Neurodegeneration in the Retina and Brain of Transgenic Mice
J. Virol.,
October 1, 2007;
81(19):
10340 - 10351.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Holst, C. Orskov, K. Qvortrup, J. P. Christensen, and A. R. Thomsen
CCR5 and CXCR3 Are Dispensable for Liver Infiltration, but CCR5 Protects against Virus-Induced T-Cell-Mediated Hepatic Steatosis
J. Virol.,
September 15, 2007;
81(18):
10101 - 10112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Shapiro, C. S. Jack, Y. Lapierre, N. Arbour, A. Bar-Or, and J. P. Antel
Potential for interferon Beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
Arch Neurol,
September 1, 2006;
63(9):
1296 - 1299.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Christensen, C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen
CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System
J. Immunol.,
April 1, 2006;
176(7):
4235 - 4243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jha, J.-H. Sohn, Q. Xu, H. Nishihori, Y. Wang, S. Nishihori, B. Manickam, H. J. Kaplan, P. S. Bora, and N. S. Bora
The complement system plays a critical role in the development of experimental autoimmune anterior uveitis.
Invest. Ophthalmol. Vis. Sci.,
March 1, 2006;
47(3):
1030 - 1038.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Tsunoda, L.-Q. Kuang, M. Kobayashi-Warren, and R. S. Fujinami
Central Nervous System Pathology Caused by Autoreactive CD8+ T-Cell Clones following Virus Infection
J. Virol.,
December 1, 2005;
79(23):
14640 - 14646.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Lee, F. Giannoni, A. Lyon, S. Yada, B. Lu, C. Gerard, and S. R. Sarawar
Role of CXCR3 in the Immune Response to Murine Gammaherpesvirus 68
J. Virol.,
July 15, 2005;
79(14):
9351 - 9355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
